seventy-one previously untreated patients with small cell lung cancer ( sclc ) received a combination of vp-16 , vincristine , doxorubicin ( adriamycin ) , and cyclophosphamide ( evac ) repeated every three weeks .
C0010583
cyclophosphamide
C0058928
evac